These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2393325)

  • 1. Effectiveness of low-dose lovastatin in lowering serum cholesterol. Experience with 56 patients.
    Bates MC; Warren SG; Grubb S; Chillag S
    Arch Intern Med; 1990 Sep; 150(9):1947-50. PubMed ID: 2393325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued benefit of lovastatin in the treatment of hypercholesterolemia in 36 patients.
    Wallace MB; Warren SG; Bates MC; Robinson PA
    W V Med J; 1995 Feb; 91(2):50-3. PubMed ID: 7610642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M; Bonnefous F; Debbas N; Irvine A
    Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
    Stugaard M; Wiig I; Lund H; Ose L; Norseth J
    Tidsskr Nor Laegeforen; 1992 Aug; 112(20):2642-6. PubMed ID: 1412289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Examination of cortisol and insulin levels in serum of patients with primary hyperlipoproteinemia and phenotype IIa and IIb during lovastatin treatment].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(11):365-8. PubMed ID: 1306568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of extended-release niacin with lovastatin for hypercholesterolemia: assessing all reasonable doses with innovative surface graph analysis.
    Insull W; McGovern ME; Schrott H; Thompson P; Crouse JR; Zieve F; Corbelli J
    Arch Intern Med; 2004 May; 164(10):1121-7. PubMed ID: 15159270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe primary hypercholesterolemia with lovastatin (Mevacor). A new therapeutic principle].
    Leth A; Munch M; Nielsen B; Dollerup J
    Ugeskr Laeger; 1990 Nov; 152(45):3354-7. PubMed ID: 2238228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the HMG-CoA-reductase inhibitor lovastatin on cholesterol saturation index and nucleation time of duodenal bile.
    Nitsche R; Schlage J; Ramin V; Kirchhoff S; Fölsch UR; Creutzfeldt C; Creutzfeldt W
    Z Gastroenterol; 1991 May; 29(5):242-5. PubMed ID: 1950033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose lovastatin safely lowers cholesterol after cardiac transplantation.
    Kobashigawa JA; Murphy FL; Stevenson LW; Moriguchi JD; Kawata N; Kamjoo P; Brownfield E; Wilmarth J; Leonard L; Chuck C
    Circulation; 1990 Nov; 82(5 Suppl):IV281-3. PubMed ID: 2225417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(10):327-33. PubMed ID: 1308286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin).
    Fojo SS; Hoegg JM; Lackner KJ; Anchors JM; Bailey KR; Brewer HB
    Horm Metab Res; 1987 Dec; 19(12):648-52. PubMed ID: 2831127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: a retrospective, computer-based study.
    Swislocki AL; Lin K; Cogburn D; Fann KY; Khuu DT; Noth RH
    Am J Manag Care; 1997 Oct; 3(10):1537-45. PubMed ID: 10178460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of combined gemfibrozil-lovastatin therapy for primary dyslipoproteinemias.
    Glueck CJ; Speirs J; Tracy T
    J Lab Clin Med; 1990 May; 115(5):603-9. PubMed ID: 2341762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.